Skip to main content

  • Monday, Oct 5th
    9:00am - 10:00am PT
    THROMBOSIS ACROSS LIFESPAN - NEW DRUGS, NEW MODELS OF CARE
    Location: Blue Theater
    PharmacoRx Track
  • Monday, Oct 5th
    9:00am - 9:07am PT
    Factor XI Inhibitors in the Wild: Where Do They Actually Fit?
    Location: Blue Theater
    Rachel Rosovsky, MD, MPH – Massachusetts General Hospital and Harvard Medical School
    PharmacoRx Track
  • Monday, Oct 5th
    9:07am - 9:14am PT
    Factor X, Factor XI, What is the Right Factor Inhibition for Carotid Disease?
    Location: Blue Theater
    Geoffrey Barnes, MD, MSc – University of Michigan
    PharmacoRx Track
  • Monday, Oct 5th
    9:14am - 9:21am PT
    The New Alphabet Soup of PE Risk Stratification
    Location: Blue Theater
    Gregory Piazza, MD – Brigham and Women's Hospital
    PharmacoRx Track
  • Monday, Oct 5th
    9:21am - 9:34am PT
    Panel Discussion
    Location: Blue Theater
    PharmacoRx Track
  • Monday, Oct 5th
    9:34am - 9:41am PT
    Obesity, Renal Dysfunction, and Cancer: When Are DOACs Not Enough?
    Location: Blue Theater
    Gaurav Parmar, MD, MPH – Massachusetts General Hospital
    PharmacoRx Track
  • Monday, Oct 5th
    9:41am - 9:48am PT
    ED and Outpatient PE Pathways: Who Can Go Home, and With What Follow-Up?
    Location: Blue Theater
    Ana Casanegra, MD – Mayo Clinic
    PharmacoRx Track
  • Monday, Oct 5th
    9:48am - 10:00am PT
    Panel Discussion
    Location: Blue Theater
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:15am - 9:15am PT
    PHARMACORX POTPOURRI: AORTA, ATERIOPATHIES, AND SYSTEMIC RISK
    Location: Blue Theater
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:15am - 8:22am PT
    Medical Management of Heritable Aortopathy: Marfan, Loeys–Dietz, and Beyond
    Location: Blue Theater
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:22am - 8:29am PT
    Lp(a), Triglycerides, and Novel Lipid Agents: Do They Matter in Aortic and Carotid Disease?
    Location: Blue Theater
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:29am - 8:36am PT
    Smoking, Vaping, and “Harm Reduction”: What Actually Works for Vascular Risk?
    Location: Blue Theater
    Naomi M. Hamburg, MD – Boston Medical Center
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:36am - 8:49am PT
    Panel Discussion
    Location: Blue Theater
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:49am - 8:56am PT
    FMD, SCAD, and Other Arteriopathies: Antiplatelets, Statins, and What Not to Do
    Location: Blue Theater
    Daniella Kadian-Dodov, MD – Icahn School of Medicine at Mount Sinai
    PharmacoRx Track
  • Tuesday, Oct 6th
    8:56am - 9:03am PT
    Genetics, Polygenic Risk, and When to Order a Panel: A Practical Approach
    Location: Blue Theater
    Eri Fukaya, MD, PhD – Stanford University
    PharmacoRx Track
  • Tuesday, Oct 6th
    9:03am - 9:15am PT
    Panel Discussion
    Location: Blue Theater
    PharmacoRx Track